| 1 |
LU2026682919 |
Candriam Equities L Biotechnology, V2 - Capitalisation |
-2,62 % |
+21,75 % |
-0,21 |
| 2 |
LU1540961759 |
HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund A Cap USD |
-2,27 % |
+19,68 % |
-0,22 |
| 3 |
LU1897414642 |
Janus Henderson Horizon Biotechnology Fund E2 USD |
-4,06 % |
+28,22 % |
-0,21 |
| 4 |
LU0317020203 |
Candriam Equities L Biotechnology, V - Capitalisation |
-3,20 % |
+21,58 % |
-0,24 |
| 5 |
LU1540962054 |
HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund P Cap USD |
-2,77 % |
+20,47 % |
-0,23 |
|
|
| 66 |
LU0959058974 |
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse A (acc) CHF-H1 |
-11,71 % |
+23,37 % |
-0,59 |
|
|
| 80 |
LU0415392678 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I EUR - Accumulating |
-13,36 % |
+14,10 % |
-1,09 |
| 81 |
LU0415392249 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions B EUR - Accumulating |
-13,97 % |
+14,10 % |
-1,13 |
| 82 |
LU0767968745 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I GBP - Accumulating |
-14,27 % |
+13,15 % |
-1,24 |
| 83 |
LU0415392835 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating |
-16,64 % |
+14,95 % |
-1,25 |
| 84 |
LU0415392595 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating |
-17,22 % |
+14,95 % |
-1,28 |